GlassScriptPhysician profile
Kay C Kitchen
NPI 1467448647
$3,510.12
in general payments reported to CMS, 2019-2025
32 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $392 · 2021: $536 · 2022: $862 · 2023: $735 · 2024: $169 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $546.38 | 2019-2024 | Veozah |
| Novo Nordisk INC | $518.31 | 2019-2023 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $445.46 | 2020-2025 | Trelegy Ellipta, Shingrix, Nucala |
| Dexcom, INC. | $354.35 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $264.02 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $192.24 | 2019-2023 | |
| Amgen INC. | $168.90 | 2019-2023 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $158.16 | 2019-2022 | |
| Abbvie INC. | $122.25 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $113.03 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.92 | 2019-2021 | |
| Abbott Laboratories | $52.75 | 2022-2023 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $51.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.25 | 2019-2023 | Trintellix |
| Nestle Healthcare Nutrition INC. | $47.27 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $41.63 | 2023 | |
| Sunovion Pharmaceuticals INC. | $40.25 | 2019 | |
| Allergan, INC. | $32.86 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.52 | 2021-2022 | |
| Eisai INC. | $30.05 | 2021 | |
| Exact Sciences Corporation | $29.20 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $22.33 | 2023 | Gemtesa |
| Almatica Pharma LLC | $19.44 | 2021 | |
| Lilly USA, LLC | $15.52 | 2023 | Jardiance |
| Irhythm Technologies, INC. | $14.69 | 2023 | Zio Xt Patch |
| Paratek Pharmaceuticals, INC. | $14.41 | 2023 | Nuzyra |
| Philips North America LLC | $13.57 | 2019 | |
| Inari Medical, INC. | $13.10 | 2022 | |
| Medline Industries LP | $13.02 | 2023 | |
| Avanir Pharmaceuticals, INC. | $12.79 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.44 | 2022 | |
| Senseonics, Incorporated | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Kitchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.